| Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
|---|
| 11/27/2008 | WO2008089070A3 Combination therapy for the treatment of cancer |
| 11/26/2008 | EP1993534A1 Use of light-active indocyanine green for treating inflammatory disorders in the oral cavity |
| 11/26/2008 | EP1883641B1 Phthalocyanine derivatives, process for their preparation, pharmaceutical compositions containing them, and their use |
| 11/25/2008 | US7455858 For use in photodynamic therapy |
| 11/20/2008 | WO2008140624A2 Methods and compositions related to hybird nanoparticles |
| 11/20/2008 | US20080286255 Treatment for eye disorder |
| 11/19/2008 | EP1991673A2 Method and apparatus for acne treatment using low intensity light therapy |
| 11/19/2008 | EP1307226B1 Vitronectin receptor antagonist pharmaceuticals |
| 11/18/2008 | US7452551 Administering to the patient a contrast agent comprising, in an aqueous carrier, targeted vesicles formulated from a lipid or polymer, a perfluorocarbon gas, a targeting ligand, scanning the patient using ultrasound to obtain an image |
| 11/18/2008 | US7452530 Administering a blocking agent of tumor necrosis factors or receptors; treatment of Sin Nombre (SNV), Ebola, Marburg, Lassa, and Dengue viral disease |
| 11/18/2008 | CA2439500C Drug delivery system for hydrophobic drugs |
| 11/18/2008 | CA2329167C Method and apparatus for enhancing flux rates of a fluid in a microporated biological tissue |
| 11/13/2008 | US20080279783 Isolated nanocapsule populations and surfactant-stabilized microcapsules and nanocapsules for diagnostic imaging and drug delivery and methods for their production |
| 11/12/2008 | EP1990055A2 Methods for pretreating a subject with extracorporeal photopheresis and/or apoptotic cells |
| 11/12/2008 | EP1124607B1 Controlled removal of biological membrane by pyrotechnic charge for transmembrane transport |
| 11/11/2008 | US7449454 Metallotexaphyrin derivatives |
| 11/11/2008 | US7449315 Bifunctional energy-reversible acyl-compositions |
| 11/06/2008 | US20080275232 contacting meso-(2'-hydroxymethyl)phenyl porphyrin or meso-(2'-N,N,N-trialkylaminomethyl)phenyl porphyrin precursors with acid catalysts for a sufficient time to yield the desired conversion to naphthochlorin compounds, used for tissue-targeted therapy |
| 11/06/2008 | US20080275033 Administering Diamino-substituted phenothiazinium compound; antimicrobial photosensitisers effective against Gram negative bacteria, Gram positive bacteria; photodynamic therapy |
| 11/06/2008 | US20080275017 Aromatic sulfenates for type i phototherapy |
| 11/06/2008 | US20080274097 Using ultrasonic vibration at treatment sites to enhance efficacy of therapeutic treatment |
| 11/05/2008 | EP1987854A1 Controlled removal of biological membrane by pyrotechnic charge for transmembrane transport |
| 11/05/2008 | EP1643953A4 Regulation of matrix metalloproteinase gene expression using specific and selective electrical and electromagnetic signals |
| 11/05/2008 | CN101299998A Method for encapsulating therapeutic substances in cells |
| 10/30/2008 | WO2008088586A3 New phototherapeutic materials prepared through nanoparticle assembly |
| 10/30/2008 | WO2008055159A3 Flash photolysis therapy for regulation of physiological function |
| 10/30/2008 | US20080269112 Antineoplastic Agents Targeted via Glut Transporters |
| 10/30/2008 | US20080268033 Biologically active methylene blue derivatives |
| 10/29/2008 | EP1983965A2 Photodynamic cosmetic procedure and healing method |
| 10/29/2008 | EP1317256B1 Pharmaceutical composition having modified carrier |
| 10/23/2008 | WO2008128051A2 Fluorescent nanoparticle compositions, methods and devices |
| 10/23/2008 | US20080261960 Photosensitizers for photodynamic therapy; killing tissue, cells; anticancer agents |
| 10/23/2008 | CA2683635A1 Fluorescent nanoparticle compositions, methods, and devices |
| 10/22/2008 | CN101291705A Method and apparatus for ultrasound drug delivery and thermal therapy with phase-convertible fluids |
| 10/21/2008 | CA2336624C Farnesyl protein transferase inhibitors with in vivo radiosensitizing properties |
| 10/16/2008 | US20080255221 Novel hydroxamates as therapeutic agents |
| 10/16/2008 | US20080255214 Novel hydroxamates as therapeutic agents |
| 10/16/2008 | CA2682686A1 Methods and systems for treating cell proliferation disorders |
| 10/15/2008 | EP1980270A2 Agent for photodynamic therapy containing porous silicon and method of quantitative measurement of reactive oxygen species produced therefrom |
| 10/15/2008 | EP1377274B1 Drug delivery system for photosensitizers |
| 10/15/2008 | CN101287493A Therapy with cd4 binding peptides and radiation |
| 10/14/2008 | US7435725 Oral compositions and methods for prevention, reduction and treatment of radiation injury |
| 10/09/2008 | WO2008119950A1 Porphyrin compounds |
| 10/09/2008 | WO2008119556A2 A process to activate extracts derived from living organisms using long wave uv irradiation and compositions comprising said activated extract |
| 10/08/2008 | EP1977760A2 Method for Treating Cervical Cancer |
| 10/07/2008 | US7431925 Internal image antibodies for optical imaging and therapy |
| 10/02/2008 | WO2008116636A2 Therapeutic plaster for trigger and acupuncture points and for meridian therapy |
| 10/02/2008 | WO2008116635A2 Composition for the topical/dermic application of homeopathic agents |
| 10/02/2008 | US20080242614 Polypeptide containing valine or proline; therapy for infections |
| 10/02/2008 | US20080241262 Nanoshells and Discrete Polymer-Coated Nanoshells, Methods For Making and Using Same |
| 10/02/2008 | US20080241232 Use of green porphyrins to treat neovasculature in the eye |
| 10/02/2008 | US20080241146 Apo-2 ligand-anti-Her-2 antibody synergism |
| 10/01/2008 | EP1973569A2 Specific therapy using integrin ligands for treating cancer |
| 09/30/2008 | US7429471 regulation of matrix metalloproteinase gene expression in cartilage cells via the application of fields generated by specific and selective electric and electromagnetic signals in the treatment of diseased or injured articular cartilage. By gene expression is meant the up-regulation or down-regulation |
| 09/30/2008 | US7429458 Binding preferential protein or peptide in sample; obtain sample containing peptides or proteins, incubate with elastomeric compound, heat, separate and recover bound bioplymers |
| 09/30/2008 | US7429377 Therapeutic composition containing a plurality of immobilized proteases |
| 09/25/2008 | US20080233625 Dietary supplements for regulating the central nervous system |
| 09/24/2008 | EP1653964B1 Cancer combination therapy comprising azd2171 and zd1839 |
| 09/23/2008 | US7427657 Aromatic sulfenates for type 1 phototherapy |
| 09/23/2008 | CA2333323C Method and compositions for treatment of cancers |
| 09/23/2008 | CA2210109C Method to prevent transplant rejection |
| 09/18/2008 | WO2008110958A1 Method of controlling a release of a material carried by ultrasound sensitive particles |
| 09/18/2008 | WO2008109972A1 Homeopathic medicament useful for immunomodulation |
| 09/18/2008 | WO2008084241A3 Use of aminolevulinic acid and derivatives thereof |
| 09/18/2008 | US20080227127 Human NK3-Related Prostate Specific Gene-1 |
| 09/16/2008 | CA2307332C Magnetic resonance imaging agents for the delivery of therapeutic agents |
| 09/12/2008 | WO2008109424A1 Composition, therapy and device for treatment of nail infections |
| 09/12/2008 | WO2008108944A2 Integrated photoactive small molecules and uses thereof |
| 09/12/2008 | WO2008108941A2 Integrated photoactive peptides and uses thereof |
| 09/12/2008 | WO2008108505A1 Novel nuclear translocation peptide |
| 09/12/2008 | WO2008106983A1 A method for non-therapeutic or therapeutic photodynamic skin treatment |
| 09/12/2008 | WO2008106966A1 A method for non-therapeutic or therapeutic photodynamic skin treatment |
| 09/12/2008 | WO2007146426A3 Nanoshells for drug delivery |
| 09/11/2008 | US20080220020 Transdermal Botulinum Toxin Compositions |
| 09/10/2008 | EP1084454A4 Free-form nanofabrication using multi-photon excitation |
| 09/10/2008 | CN101262859A Conjugated aromatic compounds for diagnosis and therapy |
| 09/04/2008 | WO2008104633A1 Method for releasing a material in a controlled manner from amphiphilic compounds and use of the method |
| 09/04/2008 | US20080213355 Polymer shell is biodegradable polylactide, polyglycolide; therapeutic drug and gas dissolved in solvent; drug released from shell by ultrasound rupture of shell; form shell by drop-by-drop emulsification; inkjet printing, cross-flow emulsification; remove solvent from emulsion by agitation, extraction |
| 09/03/2008 | EP1962905A1 Method for the inactivation of pathogens in donor blood, blood plasma or erythrocyte concentrations in flexible containers using agitation |
| 09/03/2008 | EP1370253B1 Use of alpha, beta unsaturated aryl sulfones for protecting cells and tissues from ionizing radiation toxicity |
| 09/03/2008 | EP1253943B1 Photodynamic therapy for treating conditions of the eye |
| 09/03/2008 | CN100415236C Cancer combination therapy comprising AZD217 and ZD1839, medicament box, and pharmaceutical use of AZD2171 and ZD1839 |
| 09/02/2008 | US7420089 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition |
| 08/28/2008 | US20080208167 Methods and compositions to treat myocardial conditions |
| 08/28/2008 | US20080207746 Administering an ultrasonic contrast agent; imaging tissue; medical diagnosis; using halogenated xanthene compound |
| 08/28/2008 | US20080207566 Methods for the administration of amifostine and related compounds |
| 08/28/2008 | US20080206736 Administering a therapeutically effective amount of a flavin N-oxide; exposing flavin N-oxide to an activator, such that activation of the flavin N- oxide results in damage to the DNA in cancer cells without damage to the DNA in normal cells |
| 08/28/2008 | US20080206130 In vivo panning for ligands to radiation-induced molecules |
| 08/27/2008 | EP1960001A2 System and method for monitoring in vivo drug release using overhauser-enhanced nmr |
| 08/27/2008 | EP1959973A1 A method for obtaining a biologically active fraction of blood serum treated with gamma irradiation and the use thereof |
| 08/27/2008 | EP1959855A2 Benign prostate hyperplasia treatment using photosensitizer and laser ablation |
| 08/27/2008 | EP1210078B1 Improved topical medicaments and methods for photodynamic treatment of disease |
| 08/27/2008 | EP1015039B1 Oxygen delivery agents and uses for the same |
| 08/27/2008 | CN101253502A Drug, drug guidance system, magnetic detection system, and drug design method |
| 08/26/2008 | US7417038 administering to the patient an effective amount of an agent which reduces sympathetic nervous system activity; a beta receptor blocker or a compound which inhibits the effect of aldosterone |
| 08/26/2008 | US7417023 Targeted delivery of bioaffecting compounds for the treatment of cancer |
| 08/26/2008 | CA2441535C Methods for delivering nucleic acid molecules into cells and assessment thereof |
| 08/21/2008 | WO2008098299A1 Methods and systems of treating age-related macular degeneration |
| 08/21/2008 | WO2007066247A3 System and method for monitoring in vivo drug release using overhauser-enhanced nmr |
| 08/21/2008 | US20080200436 Antiangiogenic and/or vascular permeability reducing effect; cancer, solid tumors; kits |